Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;2(1):48-52.
doi: 10.4103/0974-7788.83187.

Why and how? Addressing to the two most pertinent questions about pharmacovigilance in Ayurveda

Affiliations

Why and how? Addressing to the two most pertinent questions about pharmacovigilance in Ayurveda

Sanjeev Rastogi. Int J Ayurveda Res. 2011 Jan.

Abstract

Pharmacovigilance is the outcome of a natural and implied willingness of a physician to ensure safety to his patient. This is a discipline in medicine which pragmatises the principle of first do no harm towards a wider and systematic application in clinical practice. It is however important to understand that despite of its huge potential in ensuring a safe practice of medicine through knowledge of avoidable causes of adversities, its path has never been easy. Applying principles of pharmacovigilance into the realm of traditional medicine particularly to Ayurveda is even more difficult for the issues of why and how of pharmacovigilance in light of historical practice and anecdotal evidences of safety in Ayurveda. Application of pharmacovigilance in Ayurveda thereby demands a careful and thoughtful observation of its needs and its methods of application in order to to maximize its impacts to ensure the patient safety to every extent possible.

Keywords: Adverse drug reaction; drug safety; pharmacovigilance.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

Cited by

References

    1. The importance of pharmacovigilance: Safety monitoring of medicinal products, WHO 2002. [last accessed on 2010 July 10]. Available from: http://www.who-umc.org .
    1. Meyboom RH, Egberts AC, Gribnau FW, Hekster YA. Pharmacovigilance in perspective. Drug Saf. 1999;21:429–47. - PubMed
    1. [last accessed on 2010 Feb.10]. Available from: http://nccam.nih.gov/health/ayurveda .
    1. [last accessed on 2010 July 16]. Available from: http://www.who.int/mediacentre/factsheets/fs134/en/
    1. Rastogi S, Ranjana, Singh RH. Adverse effects of Ayurvedic drugs: An overview of causes and possibilities in reference to a case of Vatsanabha (Aconite) overdosing. Int J Risk Saf Med. 2007;19:117–25.

LinkOut - more resources